60 Degrees Pharmaceuticals Says Co. May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028

Benzinga Newsdesk www.benzinga.com Neutral 93.8%

Neg 0% Neu 93.8% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001946563/000121390026064796/ea0293532-8k_60degrees.htm

Comments

No comments yet. Be the first!